These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5047904)
1. [Serum albumin binding capacity for bromsulfophthalein in patients with uremia during hemodialysis]. Erich C; Eggstein M Klin Wochenschr; 1972 Jul; 50(13):658-60. PubMed ID: 5047904 [No Abstract] [Full Text] [Related]
2. The effect of uremia and kidney transplantation on the binding capacity of albumin. Dromgoole SH Clin Chim Acta; 1974 May; 52(3):301-3. PubMed ID: 4599323 [No Abstract] [Full Text] [Related]
3. Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs. Pacifici GM; Viani A; Taddeucci-Brunelli G; Rizzo G; Carrai M; Schulz HU Ther Drug Monit; 1986; 8(3):259-63. PubMed ID: 3750366 [TBL] [Abstract][Full Text] [Related]
4. Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds. Dasgupta A; Jacques M; Malhotra D Am J Nephrol; 1996; 16(4):327-33. PubMed ID: 8739287 [TBL] [Abstract][Full Text] [Related]
5. The binding capacity of albumin and renal disease. Dromgoole SH J Pharmacol Exp Ther; 1974 Nov; 191(2):318-23. PubMed ID: 4213685 [No Abstract] [Full Text] [Related]
6. Alteration of plasma albumin in relation to decreased drug binding in uremia. Boobis SW Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044 [TBL] [Abstract][Full Text] [Related]
7. Influence of uremic toxins and nonesterified fatty acids on drug and thyroid hormone binding in serum. Lim CF; Stockigt JR Clin Chem; 1998 Nov; 44(11):2380-1. PubMed ID: 9799777 [No Abstract] [Full Text] [Related]
8. Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding. Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT Clin Pharmacol Ther; 1983 Nov; 34(5):681-8. PubMed ID: 6627828 [TBL] [Abstract][Full Text] [Related]
9. Impaired binding of drugs and endogenous ligands in renal diseases. Gulyassy PF; Depner TA Am J Kidney Dis; 1983 May; 2(6):578-601. PubMed ID: 6342372 [No Abstract] [Full Text] [Related]
10. The use of the bromsulphtalein method in investigations of the binding of substances to albumin. Kucerová L; Hoenig V Acta Univ Carol Med (Praha); 1970; 16(3):235-60. PubMed ID: 5491528 [No Abstract] [Full Text] [Related]
11. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin. Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005 [TBL] [Abstract][Full Text] [Related]
12. Binding of sulfobromophthalein (BSP) sodium by plasma albumin. Its role in hepatic BSP extraction. Baker KJ; Bradley SE J Clin Invest; 1966 Feb; 45(2):281-7. PubMed ID: 5901512 [No Abstract] [Full Text] [Related]
13. Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis. Sarnatskaya VV; Ivanov AI; Nikolaev VG; Rotellar E; von Appen K; Haspar M; Maslenny VN; Klinkmann H Artif Organs; 1998 Feb; 22(2):107-15. PubMed ID: 9491899 [TBL] [Abstract][Full Text] [Related]
14. Reduced in vitro binding of tryptophan by plasma in uremia. de Torrente A; Glazer GB; Gulyassy P Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418 [No Abstract] [Full Text] [Related]
15. Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Niwa T; Asada H; Tsutsui S; Miyazaki T Am J Nephrol; 1995; 15(6):463-7. PubMed ID: 8546166 [TBL] [Abstract][Full Text] [Related]
16. The effect of haemodialysis on the binding capacity of albumin. Dromgoole SH Clin Chim Acta; 1973 Jul; 46(4):269-72. PubMed ID: 4201249 [No Abstract] [Full Text] [Related]
17. The metabolism of human serum albumin in renal failure on conservative and dialysis therapy. Bianchi R; Mariani G; Toni MG; Carmassi F Am J Clin Nutr; 1978 Sep; 31(9):1615-26. PubMed ID: 685877 [TBL] [Abstract][Full Text] [Related]
18. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia. Mabuchi H; Nakahashi H Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090 [TBL] [Abstract][Full Text] [Related]
19. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream? Florens N; Yi D; Juillard L; Soulage CO Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629 [TBL] [Abstract][Full Text] [Related]
20. Plasma protein carbonylation in chronic uremia. Pavone B; Sirolli V; Giardinelli A; Bucci S; Forlì F; Di Cesare M; Sacchetta P; Di Pietro N; Pandolfi A; Urbani A; Bonomini M J Nephrol; 2011; 24(4):453-64. PubMed ID: 21607919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]